PTC THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ptc Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Ptc Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $57.1M, a 40.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $57.1M -$39.6M -40.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $91.2M -$8.35M -8.38% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $91.9M -$10.5M -10.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $94.1M -$10.8M -10.3% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $96.7M -$44.9M -31.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $99.5M +$23.4M +30.8% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $102M +$25M +32.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $105M +$26.2M +33.3% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $142M +$60.9M +75.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $76.1M -$6.29M -7.63% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $77.4M -$6.99M -8.28% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $78.7M -$7.11M -8.29% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $80.7M +$51.2M +174% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $82.4M +$64.7M +366% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $84.4M +$70.7M +516% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $85.8M +$72.1M +526% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $29.5M +$19.1M +184% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $17.7M +$6.97M +65.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $13.7M +$2.39M +21.2% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $13.7M Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $10.4M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $10.7M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $11.3M Jan 1, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.